Browsing by Author "Fuly, Patricia dos Santos Claro"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Hipertensão arterial e óbito em pacientes oncológicos na Covid-19Publication . Lima, Vivian Cristina Gama Souza; Andrade, Karla Biancha S. de; Pimentel, Natalia Beatriz L.; Oliveira, Adriana Maria de; Mazzoni, Vivian G.; Gondim, Gilza Pereira S.; Souza, Maria Celeste F. D.; Demberg, Rafaela R.; Alves, Paulo Jorge P.; Fuly, Patricia dos Santos ClaroIntrodução: Pacientes com câncer e hipertensão tendem a apresentar pior evolução clínica no contexto da COVID-19.Objetivo: Caracterizar pacientes oncológicos durante a pandemia da COVID-19 e associar a prevalência da hipertensão arterial severa nesta clientela com o desfecho óbito. Método: Coorte retrospectiva, que analisou dados de pacientes com câncer e diagnóstico de COVID-19 em um serviço de referência em oncologia no Rio de Janeiro. O recorte temporal foi entre 11 de março de 2020 e 11 de março de 2021, os quais foram utilizados para análise, totalizando uma amostra de 100 prontuários. As informações foram lançadas em planilha de Excel e analisadas por meio de estatística descritiva. O estudo foi aprovado pelos Comitês de Ética em Pesquisa das instituições envolvidas, pareceres nº: 4.486.636 e 4.509.083. Resultados: Prevaleceram pacientes com idade média de 58,2 anos, gênero feminino (60,6%), raça branca (62%), com o status de performance entre 0 e 1 (42%) na avaliação inicial. O tempo médio de internação foi de 16,9 dias chegando até a 74 dias de internação. O tratamento mais aplicado foi a Quimioterapia (69, %) seguido da cirurgia (46%) e radioterapia com 36%. Observou-se que a HAS foi a comorbidade mais prevalente (49%), seguida da obesidade e DM, ambas com 16%. Doenças cardiovasculares corresponderam a 27% dos pacientes, as quais incluíram insuficiência cardíaca, arritmias, doença arterial coronariana e dislipidemias. A taxa de óbito neste grupo foi de 44% e, dos pacientes hipertensos, 45,83% foi a óbito. Embora seja uma taxa alta, observa-se que este resultado não mostrou associação significativa para o desfecho. Conclusão: O estudo revelou um perfil de paciente suscetível ao agravamento da COVID-19 na clientela estudada, considerando a presença de HAS e doença oncológica concomitantemente. Este resultado norteia o enfermeiro no planejamento do cuidado para complexidade deste paciente. Sugere-se estudos que identifiquem a presença ou não do quadro de agravamento da COVID-19 na clientela estudada e sua associação com o óbito
- Scientific publications on nursing for COVID-19 in patients with cancer: scoping reviewPublication . Lima, Vivian Cristina Gama Souza; Soares, Raquel de Souza; Santos, Willian Alves dos; Alves, Paulo; Fuly, Patricia dos Santos ClaroBackground: The needs of patients with cancer must be met, especially in times of crisis. The advent of the pandemic triggered a series of strategic actions by the nursing team to preserve the health of patients and professionals—hence the importance of studies on nursing care actions provided to patients with cancer during the COVID-19 pandemic. It is known that these patients are susceptible to severe COVID-19. However, no previous review has summarized the findings of scientific studies on nursing for COVID-19 in patients with cancer. Objective:This study aims to map the topics addressed in scientific studies on nursing for COVID-19 in patients with cancer. Methods: A scoping review was conducted using the methodology described in the Joanna Briggs Institute Reviewers' Manual 2015. The research question was elaborated using the population, concept, and context framework: What topics have been studied in nursing publications about COVID-19 in adult patients with cancer? The searches were carried out in 8 databases between April and November 2021 without time restrictions. Results: In total, 973 publications were identified using the search strategies in the databases, and 12 papers were retrieved by consulting the references. A total of 31 (3.2%) publications were included in the final analysis, generating 4 thematic categories on the subject: “restructuring the services: how oncology nursing was adapted during the pandemic,” “experiences of patients and performance of the nursing team during the COVID-19 pandemic,” “protocols and recommendations for dealing with the COVID-19 pandemic,” and “challenges and the role of oncology nurses facing the COVID-19 pandemic.” Conclusions: Several strategies used by oncology nurses to face the COVID-19 pandemic in the international scenario were identified. Reports about the restructuring of services and the team's reactions to the pandemic predominated. However, there is a lack of reports regarding emotional support strategies for health care professionals. Another gap identified was the scarcity of clinical studies on the activities developed by oncology nurses. Therefore, there is a need for clinical research in the oncology area and emotional coping strategies to support oncology nurses.
- Thromboembolic events in people with cancer during the COVID-19 pandemic: case-control studyPublication . Lima, Vivian Cristina Gama Souza; Alves, Paulo Jorge Pereira; Fuly, Patricia dos Santos ClaroObjective: to analyze the association between coronavirus disease infection and thromboembolic events in people with cancer in the first year of the pandemic. Method: case-control study carried out by collecting medical records. The selected cases were adults with cancer, diagnosed with a thromboembolic event, treated in the selected service units during the first year of the pandemic. The control group included adults with cancer without a diagnosis of a thromboembolic event. Pearson’s chi-square test was applied to verify the association between risk factors and the outcome and logistic regression techniques were applied to identify the odds ratio for the occurrence of a thromboembolic event. Results: there were 388 cases and 440 control cases included in the study (ratio 1/1). Females predominated, who were white, with mean age of 58.2 (±14.8) years. Antineoplastic chemotherapy was the most used treatment and coronavirus disease was identified in 11.59% of participants. In the case group, deep vein thrombosis was more prevalent. Conclusion: the study confirmed the hypothesis that coronavirus disease infection did not increase the chance of thromboembolic events in people with cancer. For the population studied, the factors that were associated with these events were those related to cancer and its treatment.